Neurodegeneration With Brain Iron Accumulation (NBIA)

2

Review clinical trials related to Neurodegeneration With Brain Iron Accumulation (NBIA). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TIRCON International NBIA Registry

TIRCON-reg aims to * continue the provision of a global registry and natural history study for NBIA disorders * harmonize and cover existing national and single site registries * enable participation of countries and single sites that so far have no access to an NBIA registry * join forces in order to recruit sufficient numbers of patients * define the natural history of NBIA disorders * define the most appropriate outcome measures * inform the design and facilitate the conduction of clinical trials

Participants needed: 2,000
Trial details
Biological sex: AllType: ObservationalSponsor: LMU KlinikumUpdated: Jun 5, 2025Locations: 9Duration: 30 Years
Eligibility criteria

suspected or confirmed NBIA [+1]

unwillingness to participate

Status: Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

Participants needed: 600
Trial details
Age: 10+Biological sex: AllType: ObservationalSponsor: Casa di Cura San Raffaele CassinoUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Patients with diagnosis of Parkinson's Disease, Parkinsonism and Movement Disord... [+13]

There are no restrictions for participation in the study based on age, severity...